Clinical Trials in San Francisco

Showing 1261-1280 of 6,211 trials

International Rare Brain Tumor Registry

NCT05697874

The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.

AstroblastomaBCOR ITD SarcomaCNS Sarcoma+1 more

Children's National Research Institute5,800 participantsStarted Jan 2023

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +1 more locations

ACTIVE_NOT_RECRUITINGPHASE2< 1 mile

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

NCT02257528

This phase II trial studies the side effects and how well nivolumab works in treating patients with cervical cancer that has grown, come back, or spread to other places in the body. Monoclonal antibodies, such as nivolumab, may block tumor growth in different ways by targeting certain cells.

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma+3 more

National Cancer Institute (NCI)26 participantsStarted May 2015

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +330 more locations

International Rare Brain Tumor Registry

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Find Trials by Condition in San Francisco

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

CREST-2 Long-term Observational Extension Study

Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women

OCS DCD Heart + CAP Continued Follow-Up

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Safety and Effectiveness of Sonu for Pediatric Nasal Congestion

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Skin Reactions Related to Thoracic Implantable Chamber Dressings